Clinical Trial Update: Primovist Regulatory Post Marketing Surveillance (PMS)

View source ↗

Summary

This update reports the completion of Bayer's post-marketing surveillance study for Primovist (gadoxetate disodium) in patients with liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• Primovist (Gadoxetate disodium)

Snippet

Sponsor: Bayer | Conditions: Liver | Status: COMPLETED